Eisai Co Net Income

The latest net income for ESALY is $27B as of December 2022. That compares with $56B in the prior-year period — down 51.8% year over year. That is above the Healthcare sector average of $16B. Investors often review this figure alongside Eisai Co's historical trend and sector peers before judging valuation or financial health.

Over the past year, ESALY's net income moved from $56B to $27B — a 51.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eisai Co's operating scale or balance-sheet position.

Against Healthcare companies, ESALY currently prints $27B for net income, while the sector average sits near $16B. That is roughly 70.1% above the sector mean. Large gaps often invite a closer look at Eisai Co's growth, margins, and balance sheet.

A net income figure of $27B for ESALY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.

After noting ESALY's net income ($27B), review year-over-year change from $56B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.